Notice is hereby given that a separate meeting of independent Directors is scheduled to be held on Thursday , 13.03.2025 at 3:00 P.m at corporate office of the Company .

pdf

MPS Pharma Ltd.

13 Feb 2025

3.34

-4.84%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of newspaper publication w.r.t un-audited financial results for the quarter and nine months ended 31.12.2024

pdf

MPS Pharma Ltd.

12 Feb 2025

3.34

-4.84%

Corp. Note

ADVIK LABORATORIES LTD. - 531686 - Integrated Filing (Financial)

BSE India

ENCLOSED

pdf

MPS Pharma Ltd.

12 Feb 2025

3.34

-4.84%

Result

ADVIK LABORATORIES LTD. - 531686 - Submission Of Un-Audited Financial Results For The Quarter Ended 31St …

BSE India

ENCLOSED

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	0.04	0.00	0.00	-	-
Operating Profit Qtr	-0.18	-0.19	-0.18	5.3%	0.0%
Net Profit Qtr	-0.17	-0.22	-0.21	22.7%	19.0%
Earning Per Share Adjusted latest Qtr	-0.09	-0.12	-0.11	25.0%	18.2%

* Standalone data

Detailed Results

MPS Pharma Ltd.

12 Feb 2025

3.34

-4.84%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Outcome for Outcome Of The Board Meeting And …

BSE India

Outcome of the Board Meeting and Submission of Un-audited Financial Results for the quarter ended 31st December, 2024 as required u/r 33 of the SEBI (LODR) Regulations, 2015.

pdf

MPS Pharma Ltd.

25 Jan 2025

3.34

-4.84%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Intimation for Considering The Un-Audited Financial Results Of …

BSE India

ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve the Un-audited Financial Results along with limited review report of the company for the quarter and nine months ended 31st December, 2024

pdf